Grasp the trends of tumor immunotherapy accurately to promote its orderly and healthy development in China
Article
Figures
Metrics
Preview PDF
Reference
Related
Cited by
Materials
Abstract:
It has experienced nearly a hundred years from presenting a concept of tumor immunity to clinical application of the tumor immunotherapy. Until now, the tumor immunotherapy has become the most promising means of curing malignant tumors which was currently accepted from an adjuvant treatment approach of cancer. Since 2011, multiple blockers of immune checkpoints and durgs of targeted imune cells have achieved favorable clinical efficacy in the treatment of many malignant carcinomas, which has greatly promoted the pre-clinical research on the tumor immunotherapy and its clinical applications. In this review, the development trends of the tumor immunotherapy, faced problems and their corresponding countermeasures were briefly discussed based on the analysis of the current status quo of the tumor immunotherapy in the world and in China.
Keywords:
Project Supported:
Project supported by the National Natural Science Foundation of China (No.91542204, No.81622023), and the National Key Basic Research Program of China (No.2015CB964403, No. 2013CB530502)